Skip to main content

Impacted Mandibular Third Molar

0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
2 programs
Triclosan-coated Polyglactin 910 sutureN/A1 trial
Ultrasonic DeviceN/A1 trial
Active Trials
NCT07386366RecruitingEst. Jul 2026
NCT07196904CompletedEst. Aug 2025
Innovation Pharmaceuticals
1 program
Mandibular Third Molar Extraction With Primary Wound ClosureN/A1 trial
Active Trials
NCT07324213Completed122Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsTriclosan-coated Polyglactin 910 suture
City TherapeuticsUltrasonic Device
Innovation PharmaceuticalsMandibular Third Molar Extraction With Primary Wound Closure

Clinical Trials (3)

Total enrollment: 122 patients across 3 trials

NCT07386366City TherapeuticsTriclosan-coated Polyglactin 910 suture

Wound Healing and Bacterial Adherence With Triclosan-Coated Sutures After Mandibular Impacted Third Molar Surgery

Start: Oct 2025Est. completion: Jul 2026
N/ARecruiting
NCT07196904City TherapeuticsUltrasonic Device

Ultrasonic vs Rotary Instruments in Impacted Mandibular Third Molar Surgery: Clinical and Salivary CRP Outcomes

Start: Sep 2024Est. completion: Aug 2025
N/ACompleted
NCT07324213Innovation PharmaceuticalsMandibular Third Molar Extraction With Primary Wound Closure

Healing of Mandibular Third Molar Extraction Sockets Using Platelet Concentrates and Photobiomodulation

Start: Jan 2020Est. completion: Dec 2024122 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 122 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.